160 related articles for article (PubMed ID: 14525639)
1. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
6. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.
Dominguez TE; Mitchell M; Friess SH; Huh JW; Manno CS; Ravishankar C; Gaynor JW; Tabbutt S
Pediatr Crit Care Med; 2005 May; 6(3):348-51. PubMed ID: 15857537
[TBL] [Abstract][Full Text] [Related]
8. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
9. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
10. The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery.
Wasowicz M; Meineri M; McCluskey SM; Mitsakakis N; Karkouti K
J Cardiothorac Vasc Anesth; 2009 Dec; 23(6):828-34. PubMed ID: 19467888
[TBL] [Abstract][Full Text] [Related]
11. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
13. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
15. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
18. Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage.
Grizelj R; Vuković J; Filipović-Grcić B; Sarić D; Luetić T
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):413-5. PubMed ID: 16788319
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
Lamarche Y; Demers P; Poirier NC; Robitaille D; Cartier R
Can J Cardiol; 2007 Aug; 23(10):809-13. PubMed ID: 17703260
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
